BlackRock
TYRA icon

BlackRock’s Tyra Biosciences TYRA Stock Holding History

BlackRock’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.8M Buy
3,031,972
+814,043
+37% +$26.9M ﹤0.01% 2243
2026
Q1 		$84.9M Buy
2,217,929
+131,506
+6% +$4.26M ﹤0.01% 2203
2025
Q4 		$54.9M Buy
2,086,423
+216,949
+12% +$3.98M ﹤0.01% 2459
2025
Q3 		$26.2M Sell
1,869,474
-23,854
-1% -$272K ﹤0.01% 2921
2025
Q2 		$18.1M Buy
1,893,328
+197,411
+12% +$1.88M ﹤0.01% 3091
2025
Q1 		$15.8M Sell
1,695,917
-22,587
-1% -$292K ﹤0.01% 3070
2024
Q4 		$23.9M Buy
1,718,504
+202,332
+13% +$3.67M ﹤0.01% 2927
2024
Q3 		$35.6M Buy
1,516,172
+97,317
+7% +$2.04M ﹤0.01% 2675
2024
Q2 		$22.7M Buy
1,418,855
+374,630
+36% +$6.45M ﹤0.01% 2906
2024
Q1 		$17.1M Buy
1,044,225
+79,191
+8% +$1.3M ﹤0.01% 3073
2023
Q4 		$13.4M Buy
965,034
+68,582
+8% +$888K ﹤0.01% 3244
2023
Q3 		$12.3M Buy
896,452
+5,620
+0.6% +$83.3K ﹤0.01% 3209
2023
Q2 		$15.2M Buy
890,832
+223,947
+34% +$3.25M ﹤0.01% 3199
2023
Q1 		$10.7M Buy
666,885
+11,794
+2% +$140K ﹤0.01% 3280
2022
Q4 		$4.98M Buy
655,091
+32,993
+5% +$233K ﹤0.01% 3728
2022
Q3 		$5.47M Sell
622,098
-8,757
-1% -$80.1K ﹤0.01% 3716
2022
Q2 		$4.51M Buy
630,855
+47,619
+8% +$379K ﹤0.01% 3866
2022
Q1 		$6.24M Sell
583,236
-5,330
-0.9% -$63.3K ﹤0.01% 3835
2021
Q4 		$8.28M Buy
+588,566
New +$11.7M ﹤0.01% 3780

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

BlackRock's TYRA Position: Q2 2026 in Review

BlackRock increased its Tyra Biosciences (TYRA) stake by 37% in Q2 2026, buying an estimated $26.9M and bringing the position to 3,031,972 shares worth $96.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2243.

BlackRock first reported a position in TYRA in Q4 2021 and has held it in 19 quarters since. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • BlackRock held 3,031,972 shares of Tyra Biosciences worth $96.8M as of Q2 2026.
  • BlackRock bought 814,043 Tyra Biosciences shares in Q2 2026, an estimated $26.9M.
  • Tyra Biosciences made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2243 holding.
  • BlackRock first reported a position in Tyra Biosciences in Q4 2021 and has held it in 19 quarters since.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.